| Year |
Citation |
Score |
| 2022 |
Prag HA, Kula-Alwar D, Bernardi P, Di Lisa F, Murphy MP, Krieg T. Cyclophilin D knockout mice do not accumulate succinate during cardiac ischemia. Journal of Molecular and Cellular Cardiology. 173: 73-74. PMID 36209553 DOI: 10.1016/j.yjmcc.2022.09.006 |
0.337 |
|
| 2020 |
Prag HA, Pala L, Kula-Alwar D, Mulvey JF, Luping D, Beach TE, Booty LM, Hall AR, Logan A, Sauchanka V, Caldwell ST, Robb EL, James AM, Xu Z, Saeb-Parsy K, et al. Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In Vivo. Cardiovascular Drugs and Therapy. PMID 32648168 DOI: 10.1007/s10557-020-07033-6 |
0.384 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Zuurbier CJ, Bertrand L, Beauloye CR, Andreadou I, Ruiz-Meana M, Jespersen NR, Kula-Alwar D, Prag HA, Eric Botker H, Dambrova M, Montessuit C, Kaambre T, Liepinsh E, Brookes PS, Krieg T. Cardiac metabolism as a driver and therapeutic target of myocardial infarction. Journal of Cellular and Molecular Medicine. PMID 32384583 DOI: 10.1111/Jcmm.15180 |
0.3 |
|
| 2022 |
Prag HA, Aksentijevic D, Dannhorn A, Giles AV, Mulvey JF, Sauchanka O, Du L, Bates G, Reinhold J, Kula-Alwar D, Xu Z, Pellerin L, Goodwin RJA, Murphy MP, Krieg T. Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury. Circulation Research. 101161CIRCRESAHA1213. PMID 35959683 DOI: 10.1161/CIRCRESAHA.121.320717 |
0.24 |
|
| 2021 |
Yin Z, Burger N, Kula-Alwar D, Aksentijević D, Bridges HR, Prag HA, Grba DN, Viscomi C, James AM, Mottahedin A, Krieg T, Murphy MP, Hirst J. Structural basis for a complex I mutation that blocks pathological ROS production. Nature Communications. 12: 707. PMID 33514727 DOI: 10.1038/s41467-021-20942-w |
0.189 |
|
| 2020 |
Prag HA, Kula-Alwar D, Pala L, Caldwell ST, Beach TE, James AM, Saeb-Parsy K, Krieg T, Hartley RC, Murphy MP. Selective Delivery of Dicarboxylates to Mitochondria by Conjugation to a Lipophilic Cation via a Cleavable Linker. Molecular Pharmaceutics. PMID 32692564 DOI: 10.1021/acs.molpharmaceut.0c00533 |
0.084 |
|
| 2019 |
Kula-Alwar D, Prag HA, Krieg T. Targeting Succinate Metabolism in Ischemia/Reperfusion Injury. Circulation. 140: 1968-1970. PMID 31815541 DOI: 10.1161/CIRCULATIONAHA.119.042791 |
0.066 |
|
| 2020 |
Kula-Alwar D, Marber MS, Hughes SM, Hinits Y. Mef2c factors are required for early but not late addition of cardiomyocytes to the ventricle. Developmental Biology. PMID 33245870 DOI: 10.1016/j.ydbio.2020.11.008 |
0.019 |
|
| Hide low-probability matches. |